Clinical Trials Browser

Phase EARLY_PHASE1 × rucaparib × Clear all

NCT03911453 2024-10-03

Window of Opportunity Trial, PARP Inhibitor Rucaparib Affect on PD-L1 Expression in Triple Negative Breast Tumors

Phase EARLY_PHASE1 Completed

Breast Neoplasms